NAGLAZYME

Serial Number 78629370
Registration 3132316
800

Registration Progress

Application Filed
May 13, 2005
Under Examination
Approved for Publication
Feb 1, 2006
Published for Opposition
Feb 21, 2006
Registered
Aug 22, 2006

Trademark Image

NAGLAZYME

Basic Information

Serial Number
78629370
Registration Number
3132316
Filing Date
May 13, 2005
Registration Date
August 22, 2006
Published for Opposition
February 21, 2006
Renewal Date
August 22, 2016
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Sep 28, 2015
Registration
Registered
Classes
005

Rights Holder

BioMarin Pharmaceutical Inc.

03
Address
105 Digital Drive
Novato, CA 94949

Ownership History

BioMarin Pharmaceutical Inc.

Original Applicant
03
Novato, CA

BioMarin Pharmaceutical Inc.

Owner at Publication
03
Novato, CA

BioMarin Pharmaceutical Inc.

Original Registrant
03
Novato, CA

Legal Representation

Attorney
Gregory J. Chinlund

USPTO Deadlines

Next Deadline
404 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-08-22)
Due Date
August 22, 2026
Grace Period Ends
February 22, 2027

Application History

29 events
Date Code Type Description
Sep 28, 2015 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 28, 2015 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 28, 2015 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 28, 2015 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 28, 2015 E89R I TEAS SECTION 8 & 9 RECEIVED
Aug 22, 2015 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 5, 2012 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 5, 2012 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 4, 2012 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 6, 2012 E815 I TEAS SECTION 8 & 15 RECEIVED
Aug 22, 2006 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 7, 2006 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 17, 2006 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 21, 2006 PUBO A PUBLISHED FOR OPPOSITION
Feb 1, 2006 NPUB O NOTICE OF PUBLICATION
Jan 9, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 16, 2005 ALIE A ASSIGNED TO LIE
Dec 15, 2005 CRML O CORRESPONDENCE MAILED
Dec 14, 2005 CNEA R EXAMINERS AMENDMENT -WRITTEN
Dec 14, 2005 XAEC I EXAMINER'S AMENDMENT ENTERED
Dec 14, 2005 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 14, 2005 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 14, 2005 IUAF S USE AMENDMENT FILED
Dec 14, 2005 AUPC I AMENDMENT TO USE PROCESSING COMPLETE
Dec 14, 2005 IUAA P USE AMENDMENT ACCEPTED
Dec 14, 2005 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 10, 2005 DOCK D ASSIGNED TO EXAMINER
Nov 2, 2005 EAAU I TEAS AMENDMENT OF USE RECEIVED
May 20, 2005 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations, namely pharmaceuticals for use in treatment of lysosomal storage disorders
First Use Anywhere: Jun 8, 2005
First Use in Commerce: Jun 8, 2005

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...